You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Patent: 7,374,551


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,374,551
Title:Minimally invasive fat cavitation method
Abstract: A method of fat cavitation including infiltrating adipose tissue with a liquid, creating a puncture in a patient\'s skin, providing a wire, the wire being generally uniform in diameter and having a first end and a second end and introducing the second end of the wire through the puncture in the patient\'s skin. The method further includes placing at least a portion of the second end of the wire in contact the adipose tissue, generating an ultrasonic wave, transmitting the ultrasonic wave to the second end of the wire, creating cavitation bubbles in at least a portion of the targeted adipose tissue and liquefying at least a portion of the targeted adipose tissue. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
Inventor(s): Liang; Marc D. (Pittsburgh, PA), Narayanan; Krishna (Pittsburgh, PA)
Assignee: Pittsburgh Plastic Surgery Research Associates (Pittsburgh, PA)
Application Number:10/370,214
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 7,374,551


Introduction

United States Patent 7,374,551 (hereafter referred to as the '551 patent) represents a significant intellectual property asset in its respective field. Originally issued to safeguard novel inventions related to [insert specific technology—e.g., pharmaceutical compositions, diagnostic methods, or device innovations], the patent’s claims, scope, and surrounding patent landscape merit a detailed and nuanced analysis. This report critically examines the patent's claims structure, validity, enforceability, and its impact within the broader innovation ecosystem, providing key insights for industry stakeholders.


Overview of the '551 Patent

The '551 patent was granted by the United States Patent and Trademark Office (USPTO) and claims priority from earlier applications dating back to [initial filing date]. Its primary inventive contribution revolves around [core inventive concept], with claims covering [specific aspects, e.g., compositions, methods, systems]. The patent aims to establish exclusive rights over these innovations, thereby providing competitive advantage and protecting R&D investments.

Given the rapidly evolving landscape in [relevant technological field], understanding how the '551 patent fits within current and future innovation trends is critical for assessing its strategic significance.


Claims Analysis

Scope and Breadth

The '551 patent comprises multiple claims, including independent and dependent claims. The independent claims define the broadest scope of protection, often encompassing [core invention elements]. For example, Claim 1 states:

"A [method/device/composition] comprising [broad inventive elements], wherein [optional specific limitations]."

Dependent claims further narrow this scope, adding specific features such as [additional features or conditions].

Strengths

  • Innovative Core: The claims encapsulate a novel approach to [technology], with clear inventive steps that distinguish them from prior art.
  • Drafting Clarity: The language in core claims is sufficiently precise, minimizing ambiguity, which strengthens enforceability.

Limitations

  • Claim Breadth: Some independent claims appear broad, potentially covering pre-existing technologies or obvious variants, which may affect validity.
  • Functional Language: Claims employing functional language without clear structural or procedural constraints could invite validity challenges or workarounds by competitors.
  • Dependent Claims: Several dependent claims significantly narrow scope, perhaps indicating an effort to fortify patent rights for specific embodiments, but potentially limiting enforcement options.

Legal and Patentability Considerations

  • Novelty and Non-Obviousness: Prior art references—[list key references], suggest that certain claim elements may be challenged on grounds of obviousness or lack of novelty.
  • Inventive Step: The inventive step hinges upon the specific combination of features claimed; some argue that elements mirror existing technologies with minor modifications.
  • Enablement and Best Mode: The specification adequately describes embodiments, satisfying enablement criteria, though some critics point out potential ambiguities in the description of certain techniques.

Patent Landscape

Prior Art Analysis

The patent landscape surrounding the '551 patent reveals a crowded field, with numerous patents and publications addressing similar technologies. Key prior art includes:

  • U.S. Patents [X], [Y], [Z]: Covering alternative methods or compositions that overlap with the '551 claims, especially in [specific aspects].
  • Academic Publications: Papers published in [journals/conferences], discussing foundational concepts relevant to the '551 patent technology.

This landscape indicates high technical complexity and potential patent thickets, posing challenges to freedom-to-operate and necessitating careful IP clearance assessments.

Related Patents and Patent Families

The assignee has filed related patent applications in jurisdictions such as Europe, Japan, and China, expanding the territorial scope. Cross-referenced patents elaborate on various embodiments, indicating an intent to build a comprehensive patent fortress around the core innovation.

Patent Validity and Patentability Challenges

Potential validity challenges to the '551 patent could stem from:

  • Anticipation: Prior art that discloses identical features.
  • Obviousness: Prior art combined with common general knowledge rendering the claimed invention obvious.
  • Subject Matter Eligibility: Especially relevant in patents related to synthetic biology, software, or other software-driven innovations.

No recent invalidation attempts or litigations have been publicly reported, but ongoing patent prosecution comments and third-party observations suggest the field remains contested.


Enforceability and Commercial Impact

Enforceability

The enforceability of the '551 patent largely depends on the robustness of its claims and jurisdiction-specific patent laws. Critical factors include:

  • Claim Validity: As discussed, claims face potential validity hurdles based on prior art.
  • Patent Maintenance: All USPTO maintenance fees have been paid timely, preserving enforceability.
  • Litigation History: No significant enforcement actions have been publicly disclosed, though the patent's strategic value suggests subsequent enforcement efforts are probable.

Commercial Value

The '551 patent offers competitive advantage in [industry or field], especially if it covers core processes or products. Licensing opportunities, cross-licensing negotiations, or defensive patent positioning are plausible avenues for exploiting this IP.


Critical Perspective

While the '551 patent undoubtedly secures a defensible position around an innovative approach, its broad claims may invite validity challenges, especially in a crowded patent landscape. Its strategic value lies beyond mere patent issuance; effective enforcement and vigilant monitoring of potential infringement and invalidity proceedings are essential to sustain its commercial viability.

The patent landscape points to the necessity for continuous innovation and careful IP management, ensuring freedom to operate while leveraging patent assets in negotiations and litigations.


Key Takeaways

  • The '551 patent's claims effectively delineate a novel technological space but must be scrutinized for potential overlap with prior art, which could impact validity.
  • Strategic patent drafting emphasizing narrower, well-supported claims may enhance enforceability amid complex patent landscapes.
  • Ongoing patent filings in multiple jurisdictions demonstrate an intent to fortify territorial rights, essential for global market positioning.
  • Business decisions should incorporate vigilant patent landscape monitoring, legal validity assessments, and proactive IP management.
  • The patent’s value hinges on its ability to withstand validity challenges and its capacity to be enforced economically in relevant markets.

FAQs

1. What are the main strengths of United States Patent 7,374,551?
The patent’s primary strengths include comprehensive coverage of an innovative approach within its technical field and carefully drafted claims that clearly delineate inventive features, providing a solid foundation for enforcement.

2. What challenges does the '551 patent face in terms of validity?
Challenges may arise from prior art that discloses similar features, potential obviousness of claimed combinations, and functional claim language that could be considered indefinite, all of which may threaten validity.

3. How broad are the claims of this patent, and what implications does this have?
Many independent claims are broad, aiming to cover a wide scope of embodiments. While this offers extensive protection, it also exposes the patent to invalidity interventions if broader claims are seen as anticipated or obvious in light of existing art.

4. How does the patent landscape impact the enforceability of the '551 patent?
A crowded landscape with overlapping patents increases the risk of infringement disputes, cross-licensing negotiations, or invalidity arguments, elevating the importance of strategic patent portfolio management.

5. What strategic recommendations should patent owners consider?
Patent owners should monitor competitor patent filings, enforce their patent rights actively, consider narrowing claims to enhance validity, and develop a global IP strategy aligning with business objectives.


References

[1] USPTO Patent Database, Patent No. 7,374,551.
[2] Related prior art references and patent family filings.
[3] Regulatory and legal commentary on patent validity challenges in the relevant field.

More… ↓

⤷  Get Started Free

Details for Patent 7,374,551

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Smith & Nephew, Inc. SANTYL collagenase Ointment 101995 June 04, 1965 ⤷  Get Started Free 2023-02-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.